Evaluating progression-free survival of EGFR exon 20ins in patients with advanced non-small lung cancer receiving EGFR inhibitors: A real-world data study

被引：0
|
作者：
Kabbaha, Suad [1 ]
Dempsey, Sarah Carder [1 ]
Thorlund, Kristian [1 ]
机构：
[1] BioSpark AI Technol, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20092
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Real-world outcomes in patients with non-small cell lung cancer with EGFR exon 20 insertion mutations receiving mobocertinib
    Mok, T. S. K.
    Liu, G.
    Nyaw, S. F.
    Curcio, H.
    Cortot, A.
    Kam, T. Y.
    Descourt, R.
    Chik, Y. K.
    Cheema, P. K.
    Gwinnutt, J. M.
    Churchill, E. N.
    Nyborn, J.
    Curran, E.
    Yin, Y.
    Chong, K.
    Tanaka-Chambers, Y.
    Kretz, J.
    Cadranel, J.
    ANNALS OF ONCOLOGY, 2023, 34 : S1698 - S1699
  • [2] Real-World Treatment Patterns and Survival in Non-Small Cell Lung Cancer Patients with EGFR Exon 20 Insertion Mutations
    Dersarkissian, M.
    Bhak, R.
    Lin, H.
    Li, S.
    Cheng, M.
    Lax, A.
    Huang, H.
    Duh, M.
    Ou, S.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S681 - S681
  • [3] EGFR Exon 20 insertion: Prognostic and predictive values in advanced non-small cell lung cancer, a real-world study.
    Chouaid, Christos
    Filleron, Thomas
    Debieuvre, Didier
    Perol, Maurice
    Girard, Nicolas
    Dansin, Eric
    Gervais, Radj
    Cousin, Sophie
    Otto, Josiane
    Schott, Roland
    Planchard, David
    Madroszyk, Anne
    Kaderbhai, Coureche
    Dubray-Longeras, Pascale
    Hiret, Sandrine
    Pichon, Eric
    Clement-Duchene, Christelle Anne
    Martin, Anne-Laure
    Simon, Gaetane
    Quantin, Xavier
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [4] A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
    Chouaid, Christos
    Filleron, Thomas
    Debieuvre, Didier
    Perol, Maurice
    Girard, Nicolas
    Dansin, Eric
    Lena, Herve
    Gervais, Radj
    Cousin, Sophie
    Otto, Josiane
    Schott, Roland
    Planchard, David
    Madroszyk, Anne
    Kaderbhai, Coureche
    Dubray-Longeras, Pascale
    Hiret, Sandrine
    Pichon, Eric
    Clement-Duchene, Christelle
    Chenuc, Gaelle
    Simon, Gaetane
    Bosquet, Lise
    QUantin, Xavier
    TARGETED ONCOLOGY, 2021, 16 (06) : 801 - 811
  • [5] A Real-World Study of Patients with Advanced Non-squamous Non-small Cell Lung Cancer with EGFR Exon 20 Insertion: Clinical Characteristics and Outcomes
    Christos Chouaid
    Thomas Filleron
    Didier Debieuvre
    Maurice Pérol
    Nicolas Girard
    Eric Dansin
    Hervé Lena
    Radj Gervais
    Sophie Cousin
    Josiane Otto
    Roland Schott
    David Planchard
    Anne Madroszyk
    Courèche Kaderbhai
    Pascale DUBRAY-Longeras
    Sandrine Hiret
    Eric Pichon
    Christelle Clément-Duchêne
    Gaëlle Chenuc
    Gaëtane Simon
    Lise Bosquet
    Xavier QUantin
    Targeted Oncology, 2021, 16 : 801 - 811
  • [6] Patterns of Treatment and Real-World Outcomes of Patients With Non-small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations Receiving Mobocertinib: The EXTRACT Study
    Liu, Geoffrey
    Nyaw, Shi Feng
    Mok, Tony S. K.
    Curcio, Hubert
    Cortot, Alexis B.
    Kam, Tsz Yeung
    Descourt, Renaud
    Chik, Yin Kwan
    Cheema, Parneet
    Gwinnutt, James M.
    Churchill, Eric N.
    Nyborn, Justin
    Curran, Eileen
    Savell, Alexandra
    Yin, Yu
    Chong, Katie
    Tanaka-Chambers, Yuka
    Kretz, Julian
    Cadranel, Jacques
    CANCER MEDICINE, 2025, 14 (03):
  • [7] A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations
    Huanlan Sa
    Yan Shi
    Chunxia Ding
    Kewei Ma
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 7729 - 7742
  • [8] A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations
    Sa, Huanlan
    Shi, Yan
    Ding, Chunxia
    Ma, Kewei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (10) : 7729 - 7742
  • [9] Indirect comparison of mobocertinib trial data vs real-world data in patients with EGFR exon 20 insertion (ex20ins)+ non-small cell lung cancer (NSCLC)
    Christopoulos, P.
    Prawitz, T.
    Hong, J-L.
    Lin, H. M.
    Hernandez, L.
    Jin, S.
    Tan, M.
    Proskorovsky, I.
    Lin, J.
    Zhang, P.
    Patel, J.
    Ou, S-H. I.
    Thomas, M.
    Stenzinger, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S49 - S49
  • [10] Association between inflammatory markers and progression-free survival in patients with advanced EGFR-mutated non-small cell lung cancer under treatment with tirosin kinasa inhibitors: Real-world data from Peru.
    Motta Guerrero, Rodrigo
    Aliaga Macha, Carlos
    Carracedo, Carlos F.
    Runciman, Thanya
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
12345